S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy.
Li J, Shu X, Xu J, Su SM, Chan UI, Mo L, Liu J, Zhang X, Adhav R, Chen Q, Wang Y, An T, Zhang X, Lyu X, Li X, Lei JH, Miao K, Sun H, Xing F, Zhang A, Deng C, Xu X.
Li J, et al. Among authors: wang y.
Nat Commun. 2022 Mar 18;13(1):1481. doi: 10.1038/s41467-022-29151-5.
Nat Commun. 2022.
PMID: 35304461
Free PMC article.